SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-014316
Filing Date
2023-03-28
Accepted
2023-03-28 18:48:19
Documents
2
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 7662
2 EXHIBIT 24.1 brhc10050266_ex24-1.htm EX-24.1 7502
  Complete submission text file 0001140361-23-014316.txt   16708
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065
Business Address
Reider Paul (Reporting) CIK: 0001970033 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36721 | Film No.: 23771248